The invention relates to imidazothiazole derivatives as well as their
pharmaceutically acceptable salts. The invention further relates to a
process for the preparation of such compounds. The compounds of the
invention are group I mGluR modulators and are therefore useful for the
control and prevention of various disorders, including acute and/or
chronic neurological disorders.